At JPM, how much health policy talk should we expect?

We’ll be watching to see how Washington’s latest policies — like that recent eyebrow-raising FTC decision or Medicare’s latest drug price negotiation plans — play into the pharma and biotech updates that make up so much of the fun. Execs from sixteen nonprofit health systems will also share updates on their operations, so expect to hear about Medicare Advantage denials, the coming funding cuts to safety net hospitals, and the government’s increased scrutiny around health care mergers.